Serum uric acid levels predict high hs-CRP levels in non-diabetic adult
More details
Hide details
Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Aging and Regenerative Medicine Concentration, Biomedical Magister Programme, Hasanuddin University, Makassar, Indonesia
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Submission date: 2023-01-30
Final revision date: 2023-03-06
Acceptance date: 2023-03-07
Online publication date: 2023-10-16
Corresponding author
Liong Boy Kurniawan   

Divison of Endocrinology and Metabolism, Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University, Perintis Kemerdekaan KM 10 Road, Makassar 90245, Indonesia. Tel.: +6281241738007.
Pol. Ann. Med. 2023;30(2):96–101
High-sensitivity C-reactive protein (hsCRP) is a microinflammation biomarker that has been widely accepted as an assessment tool for cardiovascular risk. Excess of serum uric acid levels is also linked to metabolic disorders and cardiovascular disease risk factors.

The study aimed to investigate the association between serum uric acid and cardiovascular risk defined based on hsCRP levels in non-diabetic adults.

Material and methods:
This cross-sectional study included 90 non-diabetic adult subjects which comprised 45 males and 45 females. The uric acid test was performed by enzymatic colorimetric method while hsCRP was performed by immunoturbidimetric assay. High cardiovascular risk was defined as hsCRP of more than 3 mg/L.

Results and discussion:
Serum uric acid had significant correlation with hsCRP levels in male and female subjects (r = 0.376, P = 0.011 and r = 0.378, P = 0.011, respectively). In male subjects, the uric acid cut-off of 7.415 mg/dL had 62.5% sensitivity and 83.8% specificity in predicting high cardiovascular risk (AUC = 0.671), while in females, the cut-off of 4.215 mg/dL had 73.3% sensitivity and 63.3% specificity (AUC = 0.704) in predicting the high risk. Males with uric acid of more than 7.415 mg/dL had 8.61 times having high cardiovascular risk compared those below the cut-off (P = 0.014, 95%CI = 1.609–46.07). Females with uric acid of more than 4.215 mg/dL had 4.75 times having high cardiovascular risk compared those below the cut-off (P = 0.02, 95%CI = 1.214–18.584).

Uric acid and hsCRP levels have a significant association. Serum uric acid levels may predict high cardiovascular risk defined based on hsCRP in males and females.

We thank study participants who voluntary joined this research.
None declared.
None declared.
Benn CL, Dua P, Gurrell R, et al. Physiology of hyperuricemia and urate-lowering treatments. Front Med. 2018;5:160.
Kochman P, Stompor T. Gout, hyperuricemia and chronic kidney disease: new treatment possibilities. Pol Ann Med. 2016;23(2):195–201.
Kleber ME, Delgado G, Grammer TB, et al. Uric acid and cardiovascular events: a mendelian randomization study. J Am Soc Nephrol. 2015;26(11):2831–2838.
Gomez-Marcos MA, Recio-Rodriguez JI, Patino-Alonzo MC, et al. Relationship between uric acid and vasculatur structure and function in hypertensive patients and sex-related difference. Am J Hypertens. 2013;26(5):599–607.
George J, Kataria SP, Isser HS. The corelation of serum uric acid with risk factors and severity of coronary artery disease (CAD) in acute coronary syndrome. IJCMSR. 2019;4(4):D107–D112.
Gur M, Sahin DY, Elbasan ZE, et al. Uric acid and high sensitive C-reactive protein are associated with subclinical thoracic aortic atherosclerosis. J Cardiol. 2013;61(2):144–148.
Salazar J, Martinez MS, Chavez-Castillo M, et al. C-reactive protein: an in-depth look into structure, function, and regulation. Int Sch Res Notices. 2014:653045.
Salazar J, Martinez MS, Chavez M, et al. C-reactive protein: clinical and epidemiological perspectives. Cardiol Res Pract. 2014. Article ID 605810.
Yousuf O, Mohanty BD, Martin SS, et al. High-sensitivity C-reactive protein and cardiovascular disease, a resolute belief or an elusive link?. J Am Coll Cardiol. 2013;62(5):397–408.
Fonseca FAH, Izar MCO. High-sensitivity C-reactive protein and cardiovascular disease across countries and ethnicities. Clinics. 2016;71(4):235–242.
Koziarska-Rościszewska M, Gluba-Brzózka A, Franczyk B, Rysz J. High-sensitivity C-reactive protein relationship with metabolic disorders and cardiovascular diseases risk factors. Life. 2021;11(8):742.
Hussein HKA, Dleikh FS, Al-Aaraji AJ, Al-Hindy HAAM, Mousa MJ. Biochemical causal-effect of circulatory uric acid, and hsCRP and their diagnostic correlation in admitted patients with ischemic heart diseases. J Cardiovasc Disease Res. 2020;11(2):25–31.
Demir S, Karakoyun G, Kanadasi M. Elevated high sensitivity C-reactive protein and uric acid levels in coronary artery ectasia. Acta Biochim Pol. 2014;61(4):687–691.
Rothenbacher D, Kleiner A, Koenig W, Primatesta P, Breitling LP, Brenner H. Relationship between inflammatory cytokines and uric acid levels with adverse cardiovascular outcomes in patients with stable coronary heart disease. PLoS ONE. 2012;7(9):e45907.
Li ZY, Liu B, Ji X, et al. Association between serum uric acid levels and high sensitive C-reactive protein in patients with type 2 diabetes. Zhonghua Yi Xue Za Zhi. 2017;97(28):2181–2185.
Prasad M, Matteson EL, Herrmann J, et al. Uric acid is associated with inflammation, coronary microvascular dysfunction, and adverse outcomes in postmenopausal women. Hypertension. 2017;69(2):236–242.
Malik R, Aneni EC, Shahrayar S, et al. Elevated serum uric acid is associated with vascular inflammation but not coronary artery calcification in the healthy octogenarians: the Brazilian study on healthy aging. Aging Clin Exp Res. 2016;28(2):359–362.
Ferreira TDS, Fernandes JFR, Araujo LDS, et al. Serum uric acid levels are associated with cardiometabolic risk factors in healthy young and middle-aged adults. Arq Bras Cardiol. 2018;111(6):833–840.
Ridi RE, Tallima H. Physiological functions and pathogenic potential of uric acid: a review. J Adv Res. 2017;8:487–493.
Kushiyama A, Nakatsu Y, Matsunaga Y, et al. Role of uric acid metabolism-related inflammation in the pathogenesis of metabolic syndrome components such as atherosclerosis and nonalcoholic steatohepatitis. Mediators Inflamm. 2016:8603164.
Inaba S, Sautin Y, Garcia GE, Johnson RJ. What can asymptomatic hyperuricaemia and systemic inflammation in the absence of gout tell us? Is uric acid a biomarker or does it have a pathophysiological role in driving systematic inflammation?. Rheumatology. 2013;52(6):963–965.
Spiga R, Marini MA, Mancuso E, et al. Uric acid is associated with inflammatory biomarkers and induces inflammation via activating the NF-kB signaling pathway in HepG2 cells. Arterioscler Thromb Vasc Biol. 2017;37:1241–1249.
Chaychenko T. Risk related cardiovascular changes in metabolically healthy obese adolescent. Pol Ann Med. 2016;23:87–91.
Kawamoto R, Kusunoki T, Abe M, Kohara K, Miki T. An association between body mass index and high-sensitivity C-reactive protein concentrations is influenced by age in community-dwelling persons. Ann Clin Bioch. 2013;50(5):457–464.